Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors

Nadiya M Teplyuk1, Mario Galindo1, Viktor I Teplyuk2

  • 1Department of Cell Biology and Cancer Center, Worcester, Massachusetts 01655.

Insights

Runt-related transcription factor 2 (Runx2) controls osteoblast growth by regulating G protein-coupled receptor signaling. Runx2 activates Gpr30 and represses Rgs2, enhancing responsiveness to mitogenic signals.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Bone Biology

Background:

  • Runt-related transcription factor 2 (Runx2) is crucial for osteoblast differentiation and function.
  • Runx2 levels fluctuate during the osteoblast cell cycle, peaking in G1.
  • Runx2 acts as a subnuclear effector for multiple signaling pathways.

Purpose of the Study:

  • To investigate the specific functions and target genes of Runx2 that regulate osteoblast proliferation.
  • To determine the role of Runx2's signaling interactions and DNA-binding in growth control.
  • To elucidate how Runx2 influences G protein-coupled receptor signaling in osteoblasts.

Main Methods:

  • Forced expression of wild-type and mutant Runx2 in Runx2(-/-) osteoprogenitors.
  • Analysis of Runx2 mutants defective in protein binding, nuclear matrix interaction, DNA binding, or transcriptional regulation.
  • Affymetrix expression profiling to identify Runx2 target genes.
  • RNA interference and gene overexpression to study the function of Gpr30 and Rgs2.

Main Results:

  • Forced expression of wild-type Runx2 suppressed osteoblast growth, while mutants defective in DNA binding or C-terminal functions did not.
  • Runx2 regulates genes involved in G protein-coupled receptor signaling, including Gpr30 and Rgs2.
  • Runx2 activates Gpr30 expression and represses Rgs2 expression, impacting cAMP signaling.
  • Gpr30 knockdown or Rgs2 overexpression inhibited osteoblast proliferation.

Conclusions:

  • Runx2's growth regulatory functions are dependent on its DNA-binding and C-terminal activities.
  • Runx2 modulates osteoblast proliferation by influencing cAMP-related G protein-coupled receptor signaling.
  • Runx2 sensitizes osteoblasts to mitogenic signals by activating Gpr30 and repressing Rgs2.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...